Cain Technology: Net profit in 2025 was 29.6312 million yuan, a year-on-year decrease of 79.19%.

Kain Technology released its performance report. In 2025, the total operating income reached 1.321 billion yuan, an increase of 7.35% year-on-year; net profit was 29.6312 million yuan, a decrease of 79.19% year-on-year. During the reporting period, the company made a substantial provision for asset impairment. According to the latest review advice from the National Medical Products Administration, after careful study, the company decided to voluntarily withdraw the drug registration application for Pegasys Interferon -2 injection, and accordingly made a full provision for asset impairment for the remaining development expenditure of the project.